First Trust Nasdaq Pharmaceuticals ETF (FTXH US) stock market data APIs
32.4854
0.1(0.3%)
as of December 17, 2025
Try our APIs with
free plan!
First Trust Nasdaq Pharmaceuticals ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
32.4854
Open
32.5857
High
32.6443
Low
32.3588
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get First Trust Nasdaq Pharmaceuticals ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get First Trust Nasdaq Pharmaceuticals ETF End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
First Trust Nasdaq Pharmaceuticals ETF News
New
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
The third-quarter results of the broader Medical sector, which includes major large-cap pharmaceutical companies, have been quite impressive this year, with more than 82% of sector participants having...
Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month
November marks National Alzheimer’s Disease Awareness Month in the United States, serving as a crucial reminder of the millions affected by the disease. This observance, established in 1983, has bec...
Trump administration prepares probe targeting global drug pricing — FT
[Visiting Australian Prime Minister Anthony Albanese Meets With Trump At The White House] Kevin Dietsch/Getty Images News The Trump administration is preparing to launch a new investigation under Sec...
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook
Pharma-giant Johnson & Johnson (JNJ) recently reported better-than-expected third-quarter 2025 results. The drugmaker continued its streak of earnings beat and also beat on sales estimates. The compan...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
